Bacteriophages are bacterial viruses and consist of a single-or double-stranded DNA or RNA protected by a protein capsid. They are able to infect bacteria by injecting their nucleic acids inside the host. The viruses multiply and induce lysis of the host cell, or they are stabilized as prophage, either inserted in the bacterial genome or as independent plasmid molecules. Bacteriophages represent the most numerous micro-organisms found on earth and play a major role in bacterial evolution by serving as a genomic reservoir in the environment and by promoting lateral gene transfer among bacteria through transduction. They also play a role in bacterial virulence through lysogenic conversion by encoding virulence factors. Bacteriophages, as well as their recombinant derivatives, are now used in a multitude of applications in the biotechnology and medical fields (e.g., as an alternative to antibiotics; tools for screening libraries of proteins, peptides or antibodies; vectors for protein and DNA vaccines; or as gene therapy delivery vehicles). Although most bacteriophages do not represent a threat to human health (unless they are carrying virulence factors), the use of recombinant viral particles in some instances might raise some biosafety concerns by bringing and potentially disseminating new genetic traits among bacterial populations. A thorough risk assessment evaluating the properties of the manipulated bacteriophages may be required to implement adequate containment and control measures to protect human health and the environment. This article describes the general characteristics of bacteriophages that could pose a risk to human health and the environment. Several aspects that should be addressed when manipulating them in laboratories are discussed, with illustrations of relevant examples. Finally, based on the risk assessment conclusion, biosafety recommendations (work practices, safety equipment, and waste management) are proposed.
Introduction
Bacteriophages, or more commonly called phages, were discovered nearly 100 years ago by Frederick Twort (Twort, 1915) and Felix d' Hérelle (d'Hérelle, 1917) . These small viral entities that specifically infect bacteria exist as nucleic acids (single-or doublestranded DNA/RNA, circular or linear) packaged within a protein capsid, which protects the nucleic acids from the environment. Depending on their nature, after injection of their nucleic acids inside the bacteria, phages induce: a) lysis of the bacterial host with the release of newly formed viral particles (lytic phages); or b) release of the progeny viruses by extrusion or budding without lysis of the host cell over several generations (filamentous phages); or c) reside as a stable element called prophage inside the host cell as a free plasmid molecule or integrated into the host chromosome (temperate phages). Bacteriophages are ubiquitous on earth, with an estimated 10 32 particles, and are approximately 10 times more abundant than bacteria and archaea (Ashelford et al., 2003; Chibani-Chennoufi et al., 2004) . Phages are obligate bacterial parasites and are found everywhere bacteria and archaea are present, including various terrestrial ecosystems (Ashelford et al., 2003; Breitbart & Rohwer, 2005) ; and even in extreme conditions such as the deep sea (Danovaro & Serresi, 2000) , solar salterns (Guixa-Boixareu et al., 1996) , acidic hot springs (> 80°C) (Rice et al., 2001) , alkaline lakes (pH = 10) (Jiang et al., 2004) , and Antarctic lakes (Kepner et al., 1998) . Their densities have been estimated to be up to 2.5x10 8 particles per milliliter and 1.5x10 7 particles per gram in aquatic and soil environment, respectively (Ashelford et al., 2003) . In theory, all bacteria are susceptible to viral infection, often by several types of phages (Ackermann & DuBow, 1987) . The number of phages that have been isolated and characterized likely represent only a tiny fraction of the phages existing on earth, and phages with new characteristics are continuously being isolated from different parts of the world (Broudy & Fischetti, 2003; Hanlon, 2007) . Phages are probably also the most diverse micro-organisms identified on earth. Results from sequence analysis of cultured phages and from metagenomic analysis (uncultured phage communities) have shown that a wide variety of genes are encoded by bacteriophages and that most of the genes identified from these sequences have no equivalent in currently available databases (Cann et al., 2005; Daubin & Ochman, 2004; Edwards & Rohwer, 2005; Lima-Mendez et al., 2008a) .
Soon after their discovery, bacteriophages were utilized as natural antimicrobial drugs to control bacterial infections. They are still used in Eastern Europe, contrary to Western Europe where antibiotics rapidly overtook the use of bacteriophages as antibacterial agents. However, due to the excessive use of antibiotics, the increasing prevalence of antibiotic-resistant bacteria has become a worldwide issue, and the development of alternatives to antibiotics is now one of the highest priorities in the field. Since phages have already been proven to be a good natural antimicrobial treatment, the use of phages as alternative bacterial therapeutics may have promise (Fortuna et al., 2008; Hanlon, 2007) .
Understanding phage genetics allowed the development of major basic tools still in use in recombinant DNA technologies (phage T4 DNA ligase, T7 promoter, cosmids, Cre-Lox system, and phage P1 artificial chromosomes [PACs] ). In addition, phage-based techniques (phage-display or phage typing) have become routine procedures in molecular biology laboratories and have been adapted to various further applications. For example, bacteriophages are now used as delivery vehicles for protein and DNA vaccines (Clark & March, 2004; Jepson & March, 2004; Lankes et al., 2007) , as potential gene therapy vectors Larocca et al., 2002) , and in nanotechnology techniques (Merzlyak et al., 2009) .
Most phages do not a priori display any risk for human health or the environment, explaining why scientific literature on bacteriophage biosafety is so scarce. However, phages correspond to dynamic entities that interact with their bacterial host and their environment, and consequently some of them possess properties (virulence genes) that may negatively impact human health. Since phage manipulation can actually represent a risk to human health, these activities are covered by European Directive 2000/54/EC related to the exposure of workers to biological agents. Furthermore, for research involving the use of genetically modified bacteriophages, a risk assessment should be made in agreement with the specification of European Directive 2009/41/EC related to the contained use of genetically modified microorganisms (GMM), which includes manipulations in laboratories, animal facilities, greenhouses, and large-scale facilities. In the United States, such research must comply with the National Institutes of Health (NIH) guidelines specifying practices for constructing and handling recombinant DNA molecules, and organisms and viruses containing recombinant DNA molecules.
This article offers a comprehensive overview of the biological risks to human health and the environment inherent to bacteriophages. Based on risk assessment conclusions, biosafety recommendations such as work practices, safety equipment, and waste management are proposed. Finally, issues that should be addressed when manipulating phages in contained facilities, together with some examples, are presented.
Risk Assessment
The goal of a biological risk assessment is to define biological hazards associated with an activity to eliminate or prevent risks to human health and the environment. The risk assessment, based on a case-by-case basis, includes the identification of potentially harmful properties of the (micro-)organism, which involves the careful evaluation of the inherent characteristics of the microbe together with the properties acquired due to genetic modifications in the case of genetically modified micro-organisms. The risk assessment also considers the type of manipulation and the probability of occurrence of the potentially harmful effects identified. Furthermore, the exposure of the environment due to possible unintended release from the contained facility (laboratory accident, wrong laboratory practices, or poor containment) has to be thoroughly analyzed. Aspects that should be considered are the expected survival of the phage, its multiplication and dissemination in the identified ecosystems, and the anticipated interaction among the phage and the organisms likely to be present in the exposed ecosystems.
Intrinsic Properties
This section summarizes the major intrinsic characteristics of bacteriophages that have to be considered when evaluating the potential risks related to their use. The genetic information encoded by the bacteriophage, its ability to transfer its genome among bacterial hosts, its host spectrum as well as its persistence in the environment are properties that should be assessed.
Pathogenicity of Phages
Generally thought to be harmless to humans, phages can actually carry virulence factors that may be transferred to bacterial populations and cause human diseases. Indeed, some examples of well-known bacteria, such as Vibrio cholera, Streptococcus pyogenes, or Escherichia coli O157:H7, have gained their pathogenicity thanks to the acquisition of phages in their genomes (Broudy & Fischetti, 2003; Sulakvelidze et al., 2001) . Cured of these phages, the pathogenic strains become non-pathogenic again, providing evidence that phages can sometimes be the actual vector that spreads disease among humans. Table 1 shows some examples of the potentially harmful phages encoding toxins. Besides coding for toxins, phages can also encode virulence factors that can affect all stages of the bacterial infectious process such as bacterial adhesion (Streptococcus mitis) or bacterial invasion of human tissues (Group A Streptococcus [GAS] or Salmonella enterica). Phages can also enhance bacterial resistance to serum and phagocytes (E. coli or Pseudomonas aeruginosa) or alter bacterial susceptibility to antibiotics (Staphylococcus aureus or S. pyogenes) by transferring resistance genes through generalized transduction (Wagner & Waldor, 2002) . The process by which phages alter the properties of the host bacteria is called "phage lysogenic conversion," and genes responsible for these alterations are called "lysogenic conversion genes" (Broudy & Fischetti, 2003; Sulakvelidze et al., 2001) . These examples show that sequence analysis of the entire phage genome is a crucial step in the risk assessment because it can reveal gene sequences with significant homology with known phage-encoded toxin genes, or genes encoding bacterial virulence factors.
Gene Transfer Capacity
Phages are mobile genetic elements that actually play a key role in bacterial evolution. In addition to their role in the emergence of new pathogenic strains by bringing virulence factors (see above), phages are also responsible for a great part of horizontal gene transfer that occurs in the bacterial world through transduction. Transduction is a mechanism by which a segment of the bacterial genome is inserted in a newly formed viral particle instead of the regular viral genome which can therefore be transferred to other bacteria. Phages capable of performing transduction are called transducing phages. Two mechanisms of transduction have been described, namely generalized and specialized transductions. During generalized transduction, random parts of the bacterial genome (due to chromosome and plasmid DNA degradation by the phage during infection) can be packaged into viral particles. Upon subsequent infection, bacterial genes are injected into a new bacterium and can recom-bine, by homologous recombination, with the host's genome. In this process, any single or group of bacterial genes may be transferred among genetically related bacteria at equal frequency. On the other hand, specialized transduction is restricted to temperate phages. Excision of the prophage DNA can sometimes be imprecise, and the bacterial region neighboring the insertion site of the phage can be packaged into viral particles and transferred among bacteria.
Even under optimal laboratory condition, transduction is a relatively rare event, occurring about once every 10 8 phage particles (Bushman, 2002; Chibani-Chennoufi et al., 2004) . However, considering the abundant number of phages in the environment, transduction can be considered a major player in gene transfer in the environment, affecting the evolution of natural bacterial populations. Furthermore, transduction has been proved to be an important mechanism of gene stabilization. Studies have shown that, due to transduction, a phenotype that is at a selective disadvantage in a population can be stabilized in this population (Replicon et al., 1995) . From a biosafety point of view, the introduction of new genetic material into the bacterial gene pool may have positive, negative, or neutral outcomes depending on the genetic marker introduced; thus, the nature of this genetic marker is of great importance. The dissemination of antibiotic resistance through bacteriophage transduction has been demonstrated in multipleantibiotic resistant P. aeruginosa strains (Blahova et al., 1994; Blahova et al., 1998; Blahova et al., 1999; Brab-Articles (Clynes & Dunican, 1970; Cohen & Sweeney, 1970; Schaefler, 1982) . Furthermore, the transfer among bacterial populations of pathogenicity islands (PAIs), genomic regions bearing one or more virulence genes, is also often associated with phage transduction. In S. aureus, the toxic shock syndrome toxine-1 (TSST-1) that is responsible for cases of toxic shock syndrome in humans is encoded by the tst gene that is part of the PAI element, designated SaPI1. It has been shown that this element is transduced with the help of phage 13 by the staphylococcal phages 80 at very high frequency. The mobility of SaPl1 may be responsible for the spread of TSST-1 production among S. aureus strains (Lindsay et al., 1998; Ruzin et al., 2001) . It has also been shown that phages can even participate in a larger genetic information exchange than previously thought. Gene transfer through transduction is not limited to bacteria of the same species but also occurs among bacteria from different species. Recently, Chen and co-workers observed that genetic transfer of PAI actually occurs between S. aureus and Listeria monocytogenes, a transfer that may have important implications for the evolution of human pathogens (Chen & Novick, 2009 ). S. aureus is one of the pathogenic microorganisms causing bovine mastitis, an important and expensive disease in dairy cattle, and using S. aureus phages as an alternative to antibiotics is the focus of one study (Gill et al., 2006) . By demonstrating the possible transfer of staphylococcal toxins to L. monocytogenes or to any other bacteria that can be infected by these phages, new risks of virulence transfer associated with phage therapy which can lead to inadvertent conversion of nonpathogenic bacteria can be considered. In that particular case, phages used to treat bovine mastitis should previously be tested for SaPI1 induction and transduction (Chen & Novick, 2009 ). In general, to prevent any risk associated with the use of phages, analysis of transduction capacity and host range of a particular phage should be a critical step in the risk assessment process.
Persistence and Survival in the Environment
The survival of a bacteriophage outside a host is extremely variable and depends on the nature of the phage itself. It is also highly influenced by surrounding environmental conditions, such as pH, ionic strength, temperature, soil structure, adsorption property, or sunlight. Sunlight was identified as the major destructive factor, causing up to 5% phage infectivity loss per hour in surface waters (Chibani-Chennoufi et al., 2004; Wommack et al., 1996) . Free phages can adsorb on clay minerals and on other particles, which can increase their survival and persistence in terrestrial and aquatic habitats, partly due to a protection from UV light (Kimura et al., 2008) .
Some phages can survive outside their microbial hosts for long periods of time under certain circumstances and maintain their ability to infect bacterial hosts. For example, Shiga-toxin-encoding phages have been shown to survive and remain infectious in soil for over a month and can survive osmotic changes, chlorination, and heat treatments better than their bacterial hosts (Waldor et al., 2005) . As a consequence of their resistance, phages are often able to escape inactivation by sewage or water treatment processes, food purification (Waldor et al., 2005) , and pasteurization (Madera et al., 2004) . The survival of phages that carry virulence genes represents an additional hazard since their survival could lead to the toxigenic conversion of susceptible bacterial strains present in their surrounding environment (Johannessen et al., 2005) . Tschape and coworkers have reported an outbreak of serious gastroenteritis and haemolytic uraemic syndrome (HUS) in a German nursery school and kindergarten that was linked to consumption of butter with parsley contaminated with Shiga-toxin-producing Citrobacter freundii. Since the parsley was fertilized with pig manure, it was postulated that free Stx-bacteriophages could have infected C. freundii during its growth in the manure (Tschape et al., 1995) .
The survival and persistence of manipulated phages in soil or in other environments should therefore be studied carefully to evaluate the extent of potential risks in case of release, especially if they are carrying virulence factors.
Dissemination in the Environment/Host Range
Even if free phages can survive a rather long time in the environment, they need to infect susceptible bacterial hosts to replicate and propagate themselves. The host range of a bacteriophage, defined by which bacterial strains can be infected, depends on the host cell surface receptor (proteins, lipopolysaccharide, or other cell surface components) recognized by this phage. Many phages are known to be highly specific for their receptors and are therefore characterized by a narrow host range, limiting their infectivity to a single species or to specific bacterial strains within a species (Ackermann & DuBow, 1987; . However, some phages that are able to infect a large range of bacterial species have also been identified, such as the wellknown broad-host-range phages P1, PRD1, and Mu (Jensen et al., 1998) . Phage Mu is one of the phages that has developed efficient strategies to broaden its host range by genetic modifications. A recombinase that inverts the orientation of the receptor genes allows the synthesis of new receptors with new specificity (Kamp et al., 1978) . Bordetella spp. bacteriophages have also adapted such a mechanism to broaden their host range (Doulatov et al., 2004) . Furthermore, it has been shown that phages are not limited to a specific habitat but can move from one definite environment to another by infecting alternative hosts. This is exemplified by the fact that phages isolated from terrestrial environments can also propagate on marine microbes (Sano et al., 2004) .
Compared to phages with a narrow host range, broad-host-range phages may promote genetic diversity and genetic exchange among a wider range of bacterial populations. Determination of the host range of the manipulated bacteriophage is therefore an important step in the risk assessment process to evaluate the probability of the phage's propagation in a particular environment and its potential role in global gene transfer.
Genetic Modifications
Phages used in research laboratories are generally genetically modified to gain new characteristics more appropriate or required for the application undertaken. In addition to the intrinsic characteristics of bacteriophages, the risk assessment should therefore also take into account their properties acquired by these genetic modifications. Basically, addressing whether the host range, virulence, resistance to environmental factors, or the potential for gene transfer of the phage has been affected is particularly important. This section briefly points out general examples of genetically modified phages and their characteristics in terms of biological risks.
Phages can be engineered to express all types of foreign peptides or proteins, and the nature of the transgene is of major importance in risk assessment. Toxins and virulence factors are generally considered "hazardous gene products." However, it has to be noted that the actual hazard of the insert depends on the genetic context in which the insert is cloned. The presence of adequate promoters or regulatory sequences is an important factor in determining the level of expression of the transgene (Bergmans et al., 2008) . The expression of active toxins by a phage increases the biological risk associated with its manipulation.
In addition to inserting new genetic material to express new determinants, specific characteristics of the phage can also be modified. The host spectrum of a phage, which is determined by phage molecules that bind to receptors on the bacterial surface, is one of the characteristics that can be modified by molecular techniques. As mentioned above, phages are generally specific to one type of bacteria, but this host-specificity can be changed or expanded to other bacterial species (Merril et al., 2003; Merril et al., 2005) . In addition to this interaction between phages and cellular receptors, restriction/modification systems may also be important parameters that affect and limit the host range of a phage in some bacterial strains. One way to address this particular problem is by engineering phages with genomes that do not contain restriction sites recognized by the bacterial host (Merril et al., 2005) . Since phages with expanded host ranges are able to infect a great range of bacterial species, the probability of their dissemination into the environment is consequently higher, increasing also the probability of gene transfer among bacterial populations, which may have important consequences depending on the nature of the phage.
It is well known that phages are not naturally able to infect eukaryotic cells. This is due to major differences between bacterial and eukaryotic cells, including cell-surface molecules and intracellular machinery (Dabrowska et al., 2005) . However, certain phages can be engineered to target specific eukaryotic cells, such as tumor cells, and used as vehicles for targeted gene delivery (Hart et al., 1994; Larocca et al., 1999) . As an example, phage M13 harboring the fibroblast growth factor (FGF) on its surface can bind and penetrate in vitro COS-1 cells that over-express FGF receptors (Larocca et al., 1998) . In cases where phages are retargeted to mammalian cells, it has to be noted that these phages are eventually degraded inside the host cell without being able to produce new infectious viral particles, diminishing the risks to humans to negligible . However, the risk may be increased if the retargeted phage has been engineered to express hazardous proteins.
Type of Activity
Evaluation of the type of manipulation should be part of the risk assessment process. Phages are obligate parasites, and their use will inevitably involve the manipulation of their bacterial hosts. Consequently, assessing the risk of the activity necessitates the evaluation of the susceptible bacteria involved. In activities where phages are used as cloning vectors, non-pathogenic E. coli laboratory strains are generally manipulated. In this case, both phages and the bacterial strains do not represent any risk to human health, and therefore the risk of such an activity could be considered negligible, at least if the transgene is not considered hazardous. On the other hand, working with pathogenic bacteria, which are responsible for human or animal diseases, increases the risk of the activity. For instance, phages are routinely used in epidemiological studies to identify pathogenic bacterial species (e.g., Campylobacter spp., Salmonella spp., Shigella spp.) isolated from clinical samples performed in reference laboratories (phage-typing) (Chirakadze et al., 2009) , and the risk associated with this activity depends on the type of bacteria identified.
Furthermore, processes and equipment involved in the activity should also be assessed since they may increase the risks identified. Procedures, such as the use of sharp tools or needles that may cause accidental injuries, should be avoided whenever possible. Other practices, such as pipetting, vortexing, and centrifugation, that generate aerosols, thus increasing the probability of exposure and the risk associated to the activity, should be physically contained by using sealed rotors, capped tubes, or biosafety cabinet.
Biosafety Recommendations and Containment Measures
Before manipulating bacteriophages, some elementary precautions, listed in Table 2 , should be considered to reduce the probability of a biological hazard occurring. First, if the phage genome sequence is available, it should be characterized with particular attention paid to the presence of toxin genes or other virulence factors that increase the biological risks. If not necessary, manipulation of phages encoding virulence factors should be avoided. Otherwise, the exact nature of the virulence gene is one of the elements that determine the risk associated with the phage (high, moderate, or low) and subsequently the containment level required and the personal protection needed. Second, lytic phages, which are considered to have the least possibility for transduction, should be favored. This is based on the knowledge that phages can transfer antibiotic resistance genes, pathogenicity islands, or other genes that may present a risk for human health and the environment through transduction. Temperate phages characterized by a minimal tendency towards transduction could also be considered as having a more limited risk in terms of gene transfer. Besides their restricted transduction capacity, lytic phages are preferred for two other reasons. Compared to temperate phages, lytic phages are: 1) unable to enter into lysogeny and cannot alter the genotype of susceptible bacterial hosts, and 2) are unable to integrate their genetic material inside the bacterial chromosome upon infection, therefore avoiding mutations that could occur during DNA insertion. Third, using phages characterized by a narrow host range limits the risk of their dissemination, particularly in cases of accidental release into the environment. This can be achieved by using natural phages with a narrow host range or by genetically modifying phages to infect only specific laboratory strains (Clark & March, 2004) . Finally, nonreplicative phages can be engineered by deleting important replication functions. Those phages are considered biologically contained since survival into the environment is highly unlikely. Enforcing these precaution measures will minimize biological hazards.
The examination of biological risks related to the use of bacteriophages and the measures taken to reduce these biological risks allow the determination of an adequate containment level to optimally protect human health and the environment against the identified risks. Biosafety containment levels (BSL) range from 1 to 4, with level 1 being the lowest. Each level is associated with specific requirements and biosafety recommendations, such as good microbiological practices, training of personnel, use of safety equipment, and design specifications. Phages handled in laboratories that are engineered to present no biological risks to human health can be handled in BSL-1. However, the containment level required should be adapted depending on the bacterial strains used to propagate the bacteriophages. For example, the manipulation of the well-characterized phage M13 using a non-pathogenic bacterial strain, such as the laboratory strain E. coli K12 belonging to class of risk 1, requires only BSL-1 to ensure adequate protection. Indeed, neither the phage nor the bacterial strain represents a biological risk to human health or the environment. On the other hand, manipulation of the same phage M13 in an activity involving pathogenic bacteria such as E. coli O157:H7 requires BSL-2. The risk associated with this activity is higher due to the manipulation of pathogenic bacteria responsible for foodborne disease and therefore requires more stringent contain- Using a phage with narrow host range will limit its propagation into the environment. Some phages have a naturally narrow host range; others can be genetically modified to infect only specific laboratory strains.
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Use of replication defective phages
Deletion of essential genes for replication Non-replicative phages can be engineered by deleting an important replication function. Their propagation requires the use of specific bacterial strains able to complement the deleted function. Those phages can be considered biologically contained since survival into the environment is highly unlikely. ment measures and work practices. In the case of the manipulation of a lambdoid phage encoding verotoxins and an E. coli strain belonging to class 1 risk, BSL-2 should also be used since the phage could convert the non-pathogenic strain into a pathogenic strain of risk group 2 and therefore increase the biological risk of the activity.
Control Measures/Waste Management
Even though most bacteriophages can be classified in risk group 1 since they do not represent any risk to human health, control measures designed to reduce the probability of their dissemination should be implemented to protect the environment. Indeed, bacteriophages represent an important gene reservoir that can be transferred among bacteria, and dissemination of recombinant phages into the environment could have important impacts on the surrounding susceptible bacterial population. The main precaution that has to be taken to avoid such unwanted release consists of properly inactivating all biological wastes generated by the activity that may contain bacteriophages. Bacteriophage inactivation is also important to avoid their dissemination throughout the laboratory. Spreading of bacteriophages may actually induce lysis and therefore the loss of any susceptible bacterial cultures present in the laboratory, a problem that can still occur several months after their initial use. It is important to note that some phages, such as T1 that are capable of surviving on laboratory surfaces for years and capable of forming stable aerosols, are particularly infectious and difficult to eliminate from laboratories (Birge, 2000) . Such phage contamination is a major problem in industrial fermentation for example, especially in the dairy industry (Callanan & Klaenhammer, 2008; Sturino & Klaenhammer, 2006) . The presence of phages in food is not a safety concern since phages of bacteria used in food fermentation, mostly lactic acid bacteria, do not represent a risk to consumers. However, phage contamination is a serious concern for the production itself since phage can slow down or even stop the fermentation process and impact the product quality. Therefore, over the years, a series of specific control measures has been developed (e.g., improved sanitation, direct vat inoculation, and use of phage-resistant bacterial starters) to control this phage contamination issue (Callanan & Klaenhammer, 2008) .
Numerous studies on phage inactivation have determined treatments and chemicals to which phages are susceptible. Although susceptibility to treatment and to disinfectant varies depending on the nature of the bacteriophage, some general considerations can be drawn. Bacteriophages are generally inactivated in solution when heated to over 80°C and are extremely sensitive to acidic (pH4 or lower) or alkaline (pH11 or higher) conditions. Warm caustic solutions (0.1 M sodium peroxide at 50°C) are effective at eliminating phages from equipment that can resist such treatments. Heat treatment is also convenient to decontaminate fixed equipment because it can reach areas that may be difficult to reach with chemical sanitizers (Edmond & Moineau, 2007) . UV light is highly effective but only for surfaces it can reach, therefore limiting its use. Sodium hypochlorate (0.05%) and formaldehyde (0.02%) are disinfectants that are widely used against bacteriophages in industry, in spite of their respective corrosiveness and toxicity. It should be noted that these two disinfectants could be replaced by a solution of ascorbic acid (10 mM) with a trace amount of copper (0.05 mM of cupric chloride) (Bogosian, 2005; Murata et al., 1971; Murata et al., 1987) . This less known disinfectant solution should be more widely employed since it is a very safe disinfectant for humans and not as corrosive as sodium hypochlorite. However, it is relatively ineffective as an antibacterial (Parada & de Fabrizio, 2001 ; for a review see Bogosian, 2005) . It should be noted that ethanol has a variable efficacy against bacteriophages (70% of ethanol is generally more effective than 100% of ethanol) (Buzrul et al., 2007) . It can even be ineffective against certain bacteriophages, such as Lactobacillus bacteriophages (Briggiler Marco et al., 2009; Quiberoni et al., 2003) . Generally speaking, studies suggest a high diversity in phage resistance, and the choice of an adequate disinfectant as well as its concentration is a crucial step for optimal inactivation.
Cleaning efforts should be as thorough and systematic as possible (work surfaces and all equipment used) to remove any residual phages, and data indicating which disinfectant and inactivation treatment are effective should be readily available for all workers in the form of written standard operating procedures. Cleaning with large quantities of disinfectant solutions is the general approach. Furthermore, since phages can exist for a longer time in wet environments, spills should be immediately cleaned up and any humid area should be eliminated. Good sampling handling and storage techniques and waste management practices are also essential. Table 3 lists some biosafety measures that should be applied whenever handling phages in contained use facilities.
Phage Applications and Biosafety Recommendations
Phages have been extensively characterized, and some of them have been exploited to develop applications in research laboratories, biotechnological industries, and the medical field. They were first proposed as an alternative to antibiotics to control bacterial infections (phage therapy), as genetic tools to detect pathogenic bacteria (phage-typing), and to screen libraries of proteins, peptides, or antibodies (phage-display). They are also being engineered to develop new delivery vehicles for protein and DNA vaccines or as gene therapy delivery vehicles. This section gathers some examples of these applications, which are summarized in Table 4 , and the steps leading to the identification of the risks associated with them are described.
Phage Therapy
Due to their bacterial lytic properties, phages have been used for decades, especially in Eastern Europe, as natural antimicrobial agents to control bacterial infections in humans (Brüssow, 2005; Bruttin & Brüssow, 2005; Marza et al., 2006) and animals (Biswas et al., 2002; Dubos et al., 1943; Matsuzaki et al., 2003; Smith & Huggins, 1982; Smith et al., 1987; Soothill, 1992) . This method, called "phage therapy," uses cocktails of different lytic phages directed to specific bacterial species. The absence of major adverse effects following phage administration strongly suggested their innocuousness. However, only scarce information is available concerning the fate of the phage once administered to humans or animals, but it has been shown that phages rapidly penetrate the circulation and spread throughout the body. Persistence of bacteriophages and their concentration into animals or humans will depend on the presence or absence of susceptible bacterial hosts. Nevertheless, bacteriophages are rapidly neutralized and inactivated by antibodies as well as by the reticuloendothelial system (spleen and liver) (Dabrowska et al., 2005) . Today, due to the emergence of multi-drug resistant pathogens, interest in phages as antibacterial agents is increasing. Research using genetically modified phages with a broadened host spectrum that is more effective against a larger number of pathogenic bacteria, and phages expressing proteins with specific function, such as lethal toxins enhancing host cell killing, is in progress. In these cases, new properties of the genetically modified phage and the nature of the transgene must be thoroughly analyzed in the risk assessment process to determine the level of risk of the activity.
Cloning Vector
In research laboratories, phages are routinely used as cloning and expression vectors, especially for packag-ing relatively large amounts of foreign DNA. The most widely used phages for this application are based on Lambda, which is a well-characterized double-stranded temperate bacteriophage infecting E. coli (Chauthaiwale et al., 1992) . Since these vectors are intrinsically regarded as safe, the risks associated with their manipulation depend mainly on the nature of the inserted genetic material and the bacterial hosts used to propagate these vectors and should be assessed on a case-by-case basis. It has to be noted that most cloning vector derivatives of phage Lambda are non-replicative due to specific mutations (e.g., amber mutations), which restricts their replication to specific laboratory suppressor hosts not present in the natural environment, consequently limiting their potential propagation (Clark & March, 2004) . However, even though the probability of dissemination has been evaluated to be negligible, good microbiological practices including appropriate disinfection should be followed.
Phage Display
Phage-display technology represents another important technique routinely used in research laboratories. This technique was first used to create random peptide epitope libraries able to bind defined target molecules such as antibodies or cell surface receptors (Clark & March, 2004) . Since phages are generally derived from well-characterized phages, such as the filamentous phage M13, these phage libraries do not represent any risk to human health or the environment and do not require a higher level than BSL-1 where good microbiological practices are correctly followed. However, the biological risk could be higher if amino acid sequences encoding risk factors such as toxins are displayed on phages, especially if they are expressed in an active conformation. For example, the commercial filamentous phage fUSE5 has been engineered to display the active form of Bacillus thuringiensis insecticidal toxins Cry1Ac. Phage particles displaying this fusion protein were viable, infectious, and lethal as a purified toxin for insects susceptible to native Cry1Ac (Kasman et al., 1998) . The main biosafety measures recommended to prevent any toxicity or allergenicity towards the worker consist of wearing a lab coat and gloves. Sharp instruments should be Articles (Kirsch et al., 2008) . As already mentioned, the level of containment depends on the whole activity, and the biological material other than phages used in the activity should be evaluated. Accordingly, the manipulation of the VEEV, which belongs to the class of risk 3 for humans and animals, necessitates that experiments be conducted in a BSL-3 facility.
Phage as DNA Vaccines
Phage-display has been adapted for other applications such as using phage particles to deliver a DNA vaccine expression cassette for intracellular antigen expression in mammalian cells (Clark & March, 2004) . Phages are genetically modified to be able to target eukaryotic cells, and the gene encoding the antigen is cloned under the control of a suitable eukaryotic promoter, such as the promoter of the cytomegalovirus (CMV), in order to be expressed once the phage is transfected (Larocca et al., 1998; Larocca et al., 1999) . Any gene with an appropriate mammalian transcriptional promoter and polyadenylation signal can be inserted into a retargeted phage to promote phage-mediated gene transfer into mammalian cells. As already noted, if no risk factors are inserted into these retargeted bacteriophages, they represent only a negligible risk to human health. Even after trans- Phage DNA vaccination Using phage as a DNA vaccine delivery vehicle. Phages are taken up by the antigen presenting cells (APCs), which lead to antigen expression. The antigen will induce antibody production capable of neutralizing the parental protein (of a bacterial pathogen).
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Genes coding for known antigen are cloned into the phage genome under the control of an eukaryotic promoter.
As for the phage-display technique, the risks mainly come from the nature of the gene inserted. The genetically modified phages will be injected into a person for vaccination. A risk of unwanted propagation to the environment is plausible. Being under the control of a eukaryotic promoter, the antigen can be expressed by eukaryotic cells. Clark & March, 2004 fection into mammalian cells, the differences in the intracellular environment of mammalian cells versus bacteria make the probability of viral particle production very low (Dabrowska et al., 2005) . As a precaution, sharp instruments and manipulations that generate aerosols should be avoided, and adequate personal protection (laboratory coat and gloves) should be required to avoid any accidental injuries or exposures. Since retargeted phages can be transfected into a variety of eukaryotic cells depending on the receptors expressed on the phage surface, biosafety measures should follow those that are recommended for the host cells. In this respect, except for cell lines of non-human or nonprimate origin, all work involving cell cultures should be performed minimally under BSL-2 conditions using a Class II biosafety cabinet (Pauwels et al., 2007) .
Conclusion
The continuously increasing amount of genomic information obtained since the discovery of bacteriophages at the beginning of the 19th century allows us to recognize and understand their contribution to bacterial evolution and ecology and to use them in a variety of applications in biotechnology and medicine. Although the safety of bacteriophages has been strongly suggested by human phage therapy, it should be noted that some phages have been recognized as important contributors to bacterial virulence, in the form of bacterial lysogens (prophages), or as vectors in horizontal gene transfer through transduction. Many phages are rather resistant to environmental conditions and can survive outside their host relatively well under certain conditions. These surviving and still infectious free phages may clearly serve as a gene reservoir and, in the case of toxin-encoding phages, may become the source of new disease outbreaks by converting susceptible nontoxigenic bacteria into toxin-producing pathogens. Moreover, phages used in research applications are usually genetically engineered viruses possessing new genetic properties that are still infectious and therefore able to infect bacterial hosts and transfer their genetic material. If released into the environment, genetically modified phages may conceivably influence the balance of the ecosystem by disseminating new genetic traits.
Thus, considering phage properties (genetically modified or not), a risk assessment is required to identify potential risks associated with their manipulation in laboratories. The presence of toxin genes or any potential genes that may increase the virulence of a bacterial strain can be found by searching phage genomes against actual online databases (Lima-Mendez et al., 2008b) . Such database searches should help to assure that phages chosen are free of genes that might potentially harm human health or the environment. Phage host range, stability, and possible capacity to lysogenize and transduce should be understood to maximize safety.
Finally, it is of great importance to determine and set up specific control measures, such as adequate disinfection and phage inactivation processes, to prevent any accidental release and dissemination of the manipulated bacteriophages.
